Nasdaq:US$18.41 (+1.47) | HKEX:HK$28.35 (+1.45) | AIM:£2.90 (+0.14)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor